Takashi Abe
- Promising effect of PMX-DHP absorption therapy for acute exacerbation of IPFBy Arata Azuma, Shinji Abe, Takashi Ogura, Hiroshi Mukae, Hiroyuki Taniguchi, Masashi Bando and Yukihiko SugiyamaArata Azuma1Division of Respiratory Medicine, Infection and Oncology, Nippon Medical School, Tokyo, JapanShinji Abe1Division of Respiratory Medicine, Infection and Oncology, Nippon Medical School, Tokyo, JapanTakashi Ogura2Respiratory Medicine, Kanagawa Cardiovascuiar and Respiratory Center, Yokohama, Kanagawa, JapanHiroshi Mukae3Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, JapanHiroyuki Taniguchi4Division of Respiratory Medicine, Allergic Internal Medicine, Tosei General Hospital, Seto, Aichi, JapanMasashi Bando5Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, JapanYukihiko Sugiyama5Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi OguraDept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki TaniguchiDept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata AzumaGraduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu InoueDept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro KondohDept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori HasegawaDept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi BandoDivision of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji AbeGraduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro MochizukiRespiratory Medicine, Himeji Medical Center, Himeji, JapanKingo ChidaSecond Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias KlüglichBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi FujimotoNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro OkazakiNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke TadayasuNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru SakamotoNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko SugiyamaDivision of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi OguraDept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki TaniguchiDept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata AzumaGraduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu InoueDept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro KondohDept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori HasegawaDept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi BandoDivision of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji AbeGraduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro MochizukiRespiratory Medicine, Himeji Medical Center, Himeji, JapanKingo ChidaSecond Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias KlüglichBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi FujimotoNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro OkazakiNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke TadayasuNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru SakamotoNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko SugiyamaDivision of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Emergency department visits by adult asthma patients have been decreasing over the past two decadesBy Michiko Hibi, Akira Shiraki, Morihide Ando, Takashi Abe, Harunori Nakashima and Joe ShindoMichiko HibiRespiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanAkira ShirakiRespiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanMorihide AndoRespiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanTakashi AbeRespiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanHarunori NakashimaRespiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanJoe ShindoRespiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, Japan
- Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstrictionBy Takeshi Nabe, Tomohiko Sekioka, Michiaki Kadode, Masanori Fujii, Takashi Abe, Michiaki Horiba, Shigekatsu Kohno and Kazuhito KawabataTakeshi NabeFaculty of Pharmaceutical Sciences, Setsunan University, Osaka, JapanPharmacology, Kyoto Pharmaceutical University, Kyoto, JapanTomohiko SekiokaPharmacology, Kyoto Pharmaceutical University, Kyoto, JapanBiology & Pharmacology, Ono Pharmaceutical Co., Ltd, Osaka, JapanMichiaki KadodePharmacology, Kyoto Pharmaceutical University, Kyoto, JapanBiology & Pharmacology, Ono Pharmaceutical Co., Ltd, Osaka, JapanMasanori FujiiPharmacology, Kyoto Pharmaceutical University, Kyoto, JapanTakashi AbePneumology, Ogaki Municipal Hospital, Gifu, JapanMichiaki HoribaPneumology, Ogaki Municipal Hospital, Gifu, JapanShigekatsu KohnoPharmacology, Kyoto Pharmaceutical University, Kyoto, JapanKazuhito KawabataBiology & Pharmacology, Ono Pharmaceutical Co., Ltd, Osaka, Japan
- The prognostic factor in patients with myositis-associated interstitial lung diseaseBy Akira Shiraki, Morihide Ando, Takashi Abe, Harunori Nakashima, Michiko Hibi and Joe ShindoAkira ShirakiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanMorihide AndoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanTakashi AbeRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanHarunori NakashimaRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanMichiko HibiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanJoe ShindoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaTakashi OguraDept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki TaniguchiDept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata AzumaGraduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu InoueDept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro KondohDept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori HasegawaDept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi BandoDivision of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji AbeGraduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro MochizukiRespiratory Medicine, Himeji Medical Center, Himeji, JapanKingo ChidaSecond Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias KlüglichBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi FujimotoNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro OkazakiNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke TadayasuNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru SakamotoNippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko SugiyamaDivision of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatmentsBy Hirohisa Kano, Akira Shiraki, Joe Shindoh, Morihide Ando, Takashi Abe, Harunori Nakashima, Michiko Hibi and Sho HoriHirohisa KanoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanAkira ShirakiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanJoe ShindohRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanMorihide AndoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanTakashi AbeRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanHarunori NakashimaRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanMichiko HibiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanSho HoriRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu Japan
- Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPDBy Keiko Wakahara, Yoshihiro Suzuki, Akira Shiraki, Toyokazu Sashio, Takashi Abe, Yukari Arakawa, Daiki Goto, Joe Shindoh and Yoshinori HasegawaKeiko WakaharaDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi JapanYoshihiro SuzukiDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi JapanAkira ShirakiDepartment of Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanToyokazu SashioDepartment of Internal Medicine, Meijo Hospital, Nagoya, Aichi JapanTakashi AbeDepartment of Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanYukari ArakawaDepartment of Internal Medicine, Meijo Hospital, Nagoya, Aichi JapanDaiki GotoDepartment of Internal Medicine, Meijo Hospital, Nagoya, Aichi JapanJoe ShindohDepartment of Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanYoshinori HasegawaDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi Japan
- The analysis of prognostic factors in patients with interstitial lung diseasesBy Akira Shiraki, Morihide Ando, Takashi Abe, Harunori Nakashima, Michiko Hibi, Hirohisa Kano and Show HoriAkira ShirakiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanMorihide AndoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanTakashi AbeRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanHarunori NakashimaRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanMichiko HibiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanHirohisa KanoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanShow HoriRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu Japan
Buying books on this site
Purchases made on this website are of electronic books only. To buy printed copies of the ERS books, please visit www.ersbookshop.com
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series
